|Bid||119.87 x 1100|
|Ask||119.90 x 1000|
|Day's Range||118.75 - 123.22|
|52 Week Range||90.56 - 135.88|
|Beta (5Y Monthly)||1.25|
|PE Ratio (TTM)||19.27|
|Forward Dividend & Yield||6.52 (5.42%)|
|Ex-Dividend Date||Feb 09, 2021|
|1y Target Est||N/A|
Today, Moderna (Nasdaq: MRNA) and IBM (NYSE: IBM) announced their intentions to explore technologies, including artificial intelligence, blockchain and hybrid cloud, that could help support smarter COVID-19 vaccine management. Central to the effort will be a pilot of open, standardized, technology-enabled vaccine distribution approaches aimed to improve supply chain visibility and foster near real-time tracking of vaccine administration.
IBM (NYSE:IBM) today announced key members of the executive team to lead the independent company that will be created following the previously announced separation of IBM’s Managed Infrastructure Services business ("NewCo").
IBM (NYSE: IBM), the Official Cloud and AI partner for the Recording Academy®, announced today the launch of GRAMMY® Debates with Watson, a new digital fan experience, powered by IBM Watson's natural language processing (NLP) capabilities and cloud technologies. In addition to this new fan experience, the Recording Academy announced it is transitioning its consumer-facing online platform, GRAMMY Backstage, to a digital environment running on IBM Cloud that will seamlessly host the preshow, the GRAMMY Awards Premiere Ceremony®, and additional show content. GRAMMY Debates with Watson will run through the 63rd Annual GRAMMY Awards®, taking place on March 14.